- Companies
- Ryman Healthcare
Ryman Healthcare Valuation Multiples
Ryman Healthcare is valued at $1.1B as of October 2026, a 2.1x revenue multiple. In the last 12 months, Ryman Healthcare revenue was $515M and Ryman Healthcare EBITDA was $43M.
Ryman Healthcare Overview
About Ryman Healthcare
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
Founded
1984
HQ
Employees
150
Website
Sectors
Financials (LTM)
EV
$1.1B
Valuation Multiples
Start free trialRyman Healthcare Financials
Ryman Healthcare reported last 12-month revenue of $515M and EBITDA of $43M.
In the same LTM period, Ryman Healthcare generated $43M in EBITDA and $22M in net income.
Revenue (LTM)
Ryman Healthcare P&L
In the most recent fiscal year, Ryman Healthcare reported revenue of $473M and EBITDA of ($33M).
Ryman Healthcare is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (7%), and net margin of (21%).
Financial data powered by Morningstar, Inc.
Ryman Healthcare Stock Performance
Ryman Healthcare has current market cap of $1.1B, and enterprise value of $1.1B.
Market Cap Evolution
Ryman Healthcare's stock price is $1.05.
Ryman Healthcare share price increased by 0.9% in the last 30 days, and decreased by 36.0% in the last year.
Ryman Healthcare has an EPS (earnings per share) of $-0.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $1.1B | 1.3% | 0.9% | -16.8% | -36.0% | $-0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRyman Healthcare Valuation Multiples
Ryman Healthcare trades at 2.1x EV/Revenue multiple, and 25.0x EV/EBITDA.
EV / Revenue (LTM)
Ryman Healthcare Financial Valuation Multiples
As of October 22, 2026, Ryman Healthcare has market cap of $1.1B and EV of $1.1B.
Ryman Healthcare has a P/E ratio of 49.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ryman Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ryman Healthcare Margins & Growth Rates
Ryman Healthcare grew revenue by 16% but EBITDA decreased by 266% in the last fiscal year.
In the most recent fiscal year, Ryman Healthcare reported gross margin of 100%, EBITDA margin of (7%), and net margin of (21%).
Ryman Healthcare Margins
Ryman Healthcare Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ryman Healthcare Operational KPIs
Ryman Healthcare's revenue per employee in the last FY averaged $3.2M, while opex per employee averaged $3.2M for the same period.
Ryman Healthcare's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ryman Healthcare's Rule of X is 49% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Ryman Healthcare Competitors
Ryman Healthcare competitors include Regis Healthcare, Summerset Group Holdings, Omada Health, InnovAge, Danel (Adir Yeoshua), Clariane, Ambea, Amal Holdings AD, Oncology Institute and Ship Healthcare Holdings.
Most Ryman Healthcare public comparables operate across Long-Term Care.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $946M | $208M | 0.9x | 0.9x | 4.2x | 8.8x | |||
| $205M | $110M | 20.5x | 14.5x | 38.2x | 26.6x | |||
| $260M | ($10M) | 3.8x | 3.0x | (97.6x) | 44.0x | |||
| $990M | $26M | 1.2x | 1.2x | 47.7x | 12.3x | |||
| $938M | $77M | 1.0x | - | 11.8x | - | |||
| $6B | $1.1B | 1.6x | 1.5x | 8.2x | 7.6x | |||
| $1.6B | $287M | 1.7x | 1.5x | 9.5x | 8.1x | |||
| $712M | $84M | 1.2x | - | 10.0x | - | |||
This data is available for Pro users. Sign up to see all Ryman Healthcare competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ryman Healthcare
| When was Ryman Healthcare founded? | Ryman Healthcare was founded in 1984. |
| Where is Ryman Healthcare headquartered? | Ryman Healthcare is headquartered in New Zealand. |
| How many employees does Ryman Healthcare have? | As of today, Ryman Healthcare has over 150 employees. |
| Is Ryman Healthcare publicly listed? | Yes, Ryman Healthcare is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Ryman Healthcare? | Ryman Healthcare trades under RYM ticker. |
| When did Ryman Healthcare go public? | Ryman Healthcare went public in 1999. |
| Who are competitors of Ryman Healthcare? | Ryman Healthcare main competitors include Regis Healthcare, Summerset Group Holdings, Omada Health, InnovAge, Danel (Adir Yeoshua), Clariane, Ambea, Amal Holdings AD, Oncology Institute, Ship Healthcare Holdings. |
| What is the current market cap of Ryman Healthcare? | Ryman Healthcare's current market cap is $1.1B. |
| What is the current revenue of Ryman Healthcare? | Ryman Healthcare's last 12 months revenue is $515M. |
| What is the current revenue growth of Ryman Healthcare? | Ryman Healthcare revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Ryman Healthcare? | Current revenue multiple of Ryman Healthcare is 2.1x. |
| What is the current EBITDA of Ryman Healthcare? | Ryman Healthcare's last 12 months EBITDA is $43M. |
| What is Ryman Healthcare's EBITDA margin? | Ryman Healthcare's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Ryman Healthcare? | Current EBITDA multiple of Ryman Healthcare is 25.0x. |
| What is the current FCF of Ryman Healthcare? | Ryman Healthcare's last 12 months FCF is $82M. |
| What is Ryman Healthcare's FCF margin? | Ryman Healthcare's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of Ryman Healthcare? | Current FCF multiple of Ryman Healthcare is 13.1x. |
| How many companies Ryman Healthcare has acquired to date? | Ryman Healthcare hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Ryman Healthcare has invested to date? | Ryman Healthcare hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Ryman Healthcare
Lists including Ryman Healthcare
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




